ArticleJAMA network open2022

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma.

Zhenguo Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.